These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
790 related articles for article (PubMed ID: 8220898)
1. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619. Cocks TM; Kemp BK; Pruneau D; Angus JA Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898 [TBL] [Abstract][Full Text] [Related]
2. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro. Kemp BK; Cocks TM Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological reactivity of human epicardial coronary arteries: phasic and tonic responses to vasoconstrictor agents differentiated by nifedipine. Stork AP; Cocks TM Br J Pharmacol; 1994 Dec; 113(4):1093-8. PubMed ID: 7889259 [TBL] [Abstract][Full Text] [Related]
4. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries. Ellwood AJ; Curtis MJ Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503 [TBL] [Abstract][Full Text] [Related]
5. Presence of vasoconstrictor 5HT1-like receptors revealed by precontraction of rabbit isolated mesenteric artery. Choppin A; O'Connor SE Br J Pharmacol; 1995 Jan; 114(2):309-14. PubMed ID: 7881730 [TBL] [Abstract][Full Text] [Related]
6. Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane. Maassen VanDenBrink A; Bax WA; Ferrari MD; Zijlstra FJ; Bos E; Saxena PR Br J Pharmacol; 1996 Nov; 119(5):855-62. PubMed ID: 8922732 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery. Tadipatri S; van Heuven-Nolsen D; Feniuk W; Saxena PR Br J Pharmacol; 1991 Dec; 104(4):887-94. PubMed ID: 1667289 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of efonidipine hydrochloride on contraction induced by several vasoconstrictors in porcine coronary artery: comparison with effects of nifedipine and nisoldipine. Higashino R; Sato R; Jin H; Inoue N; Fukuta Y; Kurimoto T; Tamaki H J Cardiovasc Pharmacol; 1997 May; 29(5):624-30. PubMed ID: 9213205 [TBL] [Abstract][Full Text] [Related]
9. Contraction of the sheep middle cerebral, pulmonary and coronary arteries initiated by release of intracellular calcium. Drummond RM; Wadsworth RM J Auton Pharmacol; 1994 Apr; 14(2):109-21. PubMed ID: 8051197 [TBL] [Abstract][Full Text] [Related]
10. Effect of thromboxane A2 antagonist GR32191B on prostanoid and nonprostanoid receptors in the human internal mammary artery. He GW; Yang CQ J Cardiovasc Pharmacol; 1995 Jul; 26(1):13-9. PubMed ID: 7564353 [TBL] [Abstract][Full Text] [Related]
11. The role of endogenous thromboxane in contractions to U46619, oxygen, 5-HT and 5-CT in the human isolated umbilical artery. Templeton AG; McGrath JC; Whittle MJ Br J Pharmacol; 1991 May; 103(1):1079-84. PubMed ID: 1878747 [TBL] [Abstract][Full Text] [Related]
12. Participation of 5-HT1-like and 5-HT2A receptors in the contraction of human temporal artery by 5-hydroxytryptamine and related drugs. Verheggen R; Freudenthaler S; Meyer-Dulheuer F; Kaumann AJ Br J Pharmacol; 1996 Jan; 117(2):283-92. PubMed ID: 8789380 [TBL] [Abstract][Full Text] [Related]
13. Contractile responses to sumatriptan in isolated bovine pulmonary artery rings: relationship to tone and cyclic nucleotide levels. Sweeney G; Templeton A; Clayton RA; Baird M; Sheridan S; Johnston ED; MacLean MR J Cardiovasc Pharmacol; 1995 Nov; 26(5):751-60. PubMed ID: 8637190 [TBL] [Abstract][Full Text] [Related]
14. Bovine isolated middle cerebral artery contractions to antimigraine drugs. Roon KI; Maassen Van Den Brink A; Ferrari MD; Saxena PR Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):591-6. PubMed ID: 10598799 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor. Stork AP; Cocks TM Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery. Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906 [TBL] [Abstract][Full Text] [Related]
17. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation. Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953 [TBL] [Abstract][Full Text] [Related]
18. 5-HT1B receptors mediate potent contractile responses to 5-HT in rat caudal artery. Craig DA; Martin GR Br J Pharmacol; 1993 Jul; 109(3):609-11. PubMed ID: 8358560 [TBL] [Abstract][Full Text] [Related]
19. Sumatriptan contracts large coronary arteries of beagle dogs through 5-HT1-like receptors. Parsons AA; Stutchbury C; Raval P; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):592-6. PubMed ID: 1335128 [TBL] [Abstract][Full Text] [Related]